(19)
(11) EP 4 172 321 A1

(12)

(43) Date of publication:
03.05.2023 Bulletin 2023/18

(21) Application number: 21736582.4

(22) Date of filing: 23.06.2021
(51) International Patent Classification (IPC): 
C12N 5/16(2006.01)
G01N 33/50(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 5/0671; C12N 2502/28; C12N 2502/1157; C12N 2502/14; C12N 2500/25; C12N 2501/11; C12N 2501/12; C12N 2533/90
(86) International application number:
PCT/EP2021/067221
(87) International publication number:
WO 2021/260049 (30.12.2021 Gazette 2021/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.06.2020 EP 20305699
19.11.2020 EP 20208781

(71) Applicant: Genfit
59120 Loos (FR)

(72) Inventors:
  • VIDAL, Guillaume
    59350 SAINT-ANDRE-LEZ-LILLE (FR)
  • WALCZAK, Robert
    59000 LILLE (FR)

(74) Representative: Cabinet Becker et AssociĆ©s 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) IN VITRO MODEL OF LIVER STEATOHEPATITIS